Table 2 Sanger sequencing validation for SNV candidates.

From: In-depth comparison of somatic point mutation callers based on different tumor next-generation sequencing depth data

Item

Varscan

SomaticSniper

Strelka

MuTect2

SNVs for Sanger resequencing

WES

23 (35.4%)

21 (32.3%)

47 (72.3%)

58 (89.2%)

65

Targeted sequencing

34 (50.0%)

31 (45.6%)

60 (88.2%)

64 (94.1%)

68

Back to article page